Ranbaxy SWOT Analysis, Competitors, Segmentation, Target Market, Positioning & USP

Published by MBA Skool Team, Last Updated: April 12, 2020

SWOT analysis of Ranbaxy analyses the brand/company with its strengths, weaknesses, opportunities & threats. In Ranbaxy SWOT Analysis, the strengths and weaknesses are the internal factors whereas opportunities and threats are the external factors.

SWOT Analysis is a proven management framework which enables a brand like Ranbaxy to benchmark its business & performance as compared to the competitors and industry. As of 2020, Ranbaxy is one of the leading brands in the pharma and healthcare sector.

The table below lists the SWOT (Strengths, Weaknesses, Opportunities, Threats), top Ranbaxy competitors and includes Ranbaxy target market, segmentation, positioning & Unique Selling Proposition (USP).

Ranbaxy SWOT Analysis, Competitors, Segmentation, Target Market, Positioning, USP & Brand Analysis Table
Ranbaxy Brand Analysis
Parent Company





Pharma and Healthcare

Tagline/ Slogan

New boundaries, new Horizons; Trusted medicines healthier lives


It is India’s largest pharmaceutical company

Ranbaxy STP
Ranbaxy Segmentation

Anti-Infectives, Cardiovascular & Diabetes, Dermatological, Neuro-Psychiatry, Pain management, Gastro-Intestinal, Nutritional

Ranbaxy Target Market

Healthcare professionals, wholesalers, generic distributors, and hospitals

Ranbaxy Positioning

A diversifies global healthcare company focused on patient’s needs

Ranbaxy SWOT Analysis
Ranbaxy Strengths

Below are the Strengths in the SWOT Analysis of Ranbaxy:

1.Top 10 Global Generic Company with a spread over 125 countries

2. over 13,000 well trained Employees, over 50 nationalities

3. Strong presence in the International market with a major share and a strong presence in India as well

4.It has operations in nearly 50 countries and has 7 manufacturing plants

Ranbaxy Weaknesses

Here are the weaknesses in the Ranbaxy SWOT Analysis:

1. It is heavily dependent upon generics for its revenue generation

2. Constantly regulated policies by the govt means operational efficiency is affected

Ranbaxy Opportunities

Following are the Opportunities in Ranbaxy SWOT Analysis:

1.increasing health awareness

2.Improvement in distribution network & brand building

3. They can leverage  Synriam, anti-malarial drug in brand building

Ranbaxy Threats

The threats in the SWOT Analysis of Ranbaxy are as mentioned:

1.Increasingly stringent FDA Regulations

2.Exchange rate fluctuations

3.Global economic slowdown

Ranbaxy Competition

Below are the top 4 Ranbaxy competitors:

1. Sun Pharma Industries
2. Dr.Reddy's

3. Lupin

4. GlaxoSmithKline Pharmaceuticals Ltd

This article has been researched & authored by the Content & Research Team. It has been reviewed & published by the MBA Skool Team. The content on MBA Skool has been created for educational & academic purpose only.

Similar analysis has also been done for the competitors of the company belonging to the same category, sector or industry. Browse marketing analysis of more brands and companies similar to Ranbaxy. The BrandGuide section covers SWOT Analysis, Competitors, Segmentation, Target Market, Positioning & USP of more than 2800 brands from over 20 industry sectors.

Search & Explore : BrandGuide

The brand names and other brand information used in the BrandGuide section are properties of their respective companies. The companies are not associated with MBA Skool in any way.
Edit the Brand or Add a New One : Contribute to BrandGuide
Share this Page on:
Facebook ShareTweetShare on Linkedin